0HC7.L

Albemarle Corporation [0HC7.L] Stock Forecast

Q: What is Albemarle Corporation stock symbol ?

Albemarle Corporation is a US stock, located in Charlotte of Nc and trading under the symbol 0HC7.L

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

0HC7.L Stock Summary

Earnings have grown 31.38% per last year.

Earnings are expected to fall -100% next year

Unstable dividend track record

EPS has been decreasing for the past 3 quarters (Quarter statements)

Top 10 Correlated ETFs

0HC7.L

Top 10 Correlated Stocks

0HC7.L

In the News

0HC7.L Financial details

Company Rating

Neutral

Market Cap

13.11B

Income

1.57B

Revenue

9.62B

Book val./share

80.2

Cash/share

7.58

Dividend

1.6

Dividend %

1.2%

Employees

Optionable

Shortable

Yes

Earnings

01 May 2024

P/E

4.73

Forward P/E

PEG

-1.14

P/S

0.01

P/B

1.59

P/C

15.31

P/FCF

0.3

Quick Ratio

0.71

Current Ratio

1.81

Debt / Equity

0.43

LT Debt / Equity

0.36

EPS (TTM)

13.34

EPS next Y

EPS next Q

EPS this Y

-41.51%

EPS next Y

EPS next 5Y

EPS last 5Y

21.62%

Revenue last 5Y

21.79%

Revenue Q/Q

1.97%

EPS Q/Q

-304.67%

SMA20

SMA50

5.13%

SMA100

-0.81%

Inst Own

Inst Trans

ROA

18%

ROE

36%

ROC

0.15%

Gross Margin

29%

Oper. Margin

23%

Profit Margin

34%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

108.52-247.2685

52W High

-53.02%

52W Low

+7.45%

RSI

Rel Volume

0.39

Avg Volume

7.72K

Volume

3.05K

Perf Week

-10.15%

Perf Month

-1.87%

Perf Quarter

-17.24%

Perf Half Y

-30.88%

Beta

1.606

Volatility

5.31%, 4.58%

Prev Close

0.83%

Price

116.05

Change

0HC7.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	33.76	29.29	28.56	62.14	81.66
Net income per share	5.02	3.52	1.06	22.84	13.36
Operating cash flow per share	6.77	7.48	2.95	16.2	11.25
Free cash flow per share	-1.25	-0.48	-5.23	5.49	-7
Cash per share	5.77	6.99	3.77	12.73	7.56
Book value per share	36.98	39.96	48.27	67.77	79.92
Tangible book value per share	20.32	22.98	33.46	53.36	68.23
Share holders equity per share	36.98	39.96	48.27	67.77	79.92
Interest debt per share	29.13	34.07	20.91	28.19	36.36
Market cap	7.65B	15.81B	27.3B	25.34B	16.95B
Enterprise value	10.22B	18.77B	29.42B	27.19B	20.37B
P/E ratio	14.34	42.07	220.77	9.42	10.77
Price to sales ratio	2.13	5.05	8.2	3.46	1.76
POCF ratio	10.63	19.79	79.31	13.28	12.79
PFCF ratio	-57.75	-306.55	-44.8	39.21	-20.57
P/B Ratio	1.94	3.7	4.85	3.17	1.8
PTB ratio	1.94	3.7	4.85	3.17	1.8
EV to sales	2.85	6	8.84	3.71	2.12
Enterprise value over EBITDA	11.37	24.77	37.39	9.7	30.36
EV to operating cash flow	14.21	23.5	85.45	14.25	15.37
EV to free cash flow	-77.2	-364.04	-48.27	42.08	-24.73
Earnings yield	0.07	0.02	0	0.11	0.09
Free cash flow yield	-0.02	0	-0.02	0.03	-0.05
Debt to equity	0.77	0.83	0.42	0.4	0.43
Debt to assets	0.31	0.34	0.21	0.21	0.22
Net debt to EBITDA	2.86	3.91	2.69	0.66	5.1
Current ratio	1.58	1.22	1.07	1.89	1.47
Interest coverage	8.25	5.08	6.26	17.58	1.28
Income quality	1.35	2.13	2.78	0.71	0.84
Dividend Yield	0.02	0.01	0.01	0.01	0.01
Payout ratio	0.29	0.43	1.44	0.07	0.12
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.02	0.02	0.02	0.01	0.01
Intangibles to total assets	0.2	0.19	0.17	0.12	0.09
Capex to operating cash flow	-1.18	-1.06	-2.77	-0.66	-1.62
Capex to revenue	-0.24	-0.27	-0.29	-0.17	-0.22
Capex to depreciation	-3.99	-3.67	-3.75	-4.19	-5
Stock based compensation to revenue	0.01	0.01	0.01	0	-0.26
Graham number	64.6	56.24	33.95	186.6	155.01
ROIC	0.08	0.06	0.05	0.19	-0.01
Return on tangible assets	0.07	0.04	0.01	0.2	0.09
Graham Net	-39.55	-41.03	-32.59	-30.92	-44.65
Working capital	816.11M	404.34M	133.65M	2.45B	1.66B
Tangible asset value	2.16B	2.45B	3.9B	6.29B	8.04B
Net current asset value	-3.54B	-3.78B	-3.16B	-2.08B	-3.39B
Invested capital	0.77	0.83	0.42	0.4	0.43
Average receivables	679.08M	695.14M	668.94M	1.07B	1.64B
Average payables	548.33M	528.68M	565.6M	1.35B	2.07B
Average inventory	734.76M	759.61M	781.58M	1.44B	2.12B
Days sales outstanding	76.51	74.41	76.78	72.23	69.65
Days payables outstanding	89.92	82.68	101.97	176.88	90.56
Days of inventory on hand	120.43	128.36	127.92	178.95	93.73
Receivables turnover	4.77	4.91	4.75	5.05	5.24
Payables turnover	4.06	4.41	3.58	2.06	4.03
Inventory turnover	3.03	2.84	2.85	2.04	3.89
ROE	0.14	0.09	0.02	0.34	0.17
Capex per share	-8.01	-7.96	-8.18	-10.71	-18.25

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	22.23	21.9	20.13	19.62	20.08
Net income per share	9.6	10.51	5.52	2.57	-5.26
Operating cash flow per share	8.08	6.12	0.63	5.34	-0.84
Free cash flow per share	4.3	2.59	-3.65	0.7	-6.67
Cash per share	12.71	13.47	13.58	13.6	7.58
Book value per share	67.69	78.18	83.34	84.03	80.2
Tangible book value per share	53.3	63.99	69.45	70.43	68.47
Share holders equity per share	67.69	78.18	83.34	84.03	80.2
Interest debt per share	27.15	27.36	29.4	30.62	35.17
Market cap	25.37B	26.07B	26.25B	20.25B	16.89B
Enterprise value	27.22B	27.86B	28.32B	22.46B	20.31B
P/E ratio	5.6	5.26	10.1	16.74	-6.84
Price to sales ratio	9.68	10.11	11.08	8.77	7.17
POCF ratio	26.64	36.16	356.18	32.21	-171.99
PFCF ratio	50.08	85.38	-61.06	244.16	-21.59
P/B Ratio	3.18	2.83	2.67	2.05	1.79
PTB ratio	3.18	2.83	2.67	2.05	1.79
EV to sales	10.39	10.8	11.95	9.72	8.62
Enterprise value over EBITDA	29.35	23.28	60.74	-1.16K	-27.15
EV to operating cash flow	28.59	38.64	384.19	35.72	-206.83
EV to free cash flow	53.74	91.23	-65.86	270.75	-25.97
Earnings yield	0.04	0.05	0.02	0.01	-0.04
Free cash flow yield	0.02	0.01	-0.02	0	-0.05
Debt to equity	0.4	0.35	0.35	0.36	0.43
Debt to assets	0.21	0.18	0.18	0.19	0.22
Net debt to EBITDA	2	1.49	4.43	-114.17	-4.57
Current ratio	1.89	1.9	1.74	1.81	1.47
Interest coverage	35.11	41.34	14.59	-4.25	-26
Income quality	0.84	0.58	0.11	2.08	0.16
Dividend Yield	0	0	0	0	0
Payout ratio	0.04	0.04	0.07	0.16	-0.08
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.01	0.01	0.01	0.01	0.01
Intangibles to total assets	0.12	0.11	0.1	0.1	0.09
Capex to operating cash flow	-0.47	-0.58	-6.83	-0.87	6.96
Capex to revenue	-0.17	-0.16	-0.21	-0.24	-0.29
Capex to depreciation	-5.21	-4.66	-5.41	-5.18	-4.69
Stock based compensation to revenue	0.01	-0.07	-0.08	-0.09	-0.12
Graham number	120.94	135.97	101.74	69.69	97.46
ROIC	0.07	0.07	0.02	-0.01	-0.07
Return on tangible assets	0.08	0.08	0.04	0.02	-0.04
Graham Net	-30.88	-31.23	-36.21	-35.12	-44.81
Working capital	2.45B	3.15B	3.16B	3.18B	1.66B
Tangible asset value	6.29B	7.54B	8.18B	8.3B	8.04B
Net current asset value	-2.08B	-1.45B	-1.57B	-1.6B	-3.39B
Invested capital	0.4	0.35	0.35	0.36	0.43
Average receivables	1.31B	1.56B	1.72B	1.74B	1.77B
Average payables	1.85B	2.41B	2.91B	2.83B	2.35B
Average inventory	1.85B	2.63B	3.42B	3.53B	2.78B
Days sales outstanding	49.74	58.06	67.25	66.52	70.1
Days payables outstanding	114.77	191.02	151.64	104.15	61.68
Days of inventory on hand	116.11	219.26	181.75	135.99	63.84
Receivables turnover	1.81	1.55	1.34	1.35	1.28
Payables turnover	0.78	0.47	0.59	0.86	1.46
Inventory turnover	0.78	0.41	0.5	0.66	1.41
ROE	0.14	0.13	0.07	0.03	-0.07
Capex per share	-3.78	-3.53	-4.28	-4.63	-5.83

0HC7.L Dividend History

0HC7.L Frequently Asked Questions

What is Albemarle Corporation stock symbol ?

Albemarle Corporation is a US stock , located in Charlotte of Nc and trading under the symbol 0HC7.L

What is Albemarle Corporation stock quote today ?

Albemarle Corporation stock price is $116.05 today.

Is Albemarle Corporation stock public?

Yes, Albemarle Corporation is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 7.72K
Market Capitalization 13.11B
Employee 9K
CEO Mr. Jerry Kent Masters Jr.
Headquarters Charlotte,NC,US
IPO Date 2018-01-29
Website https://www.albemarle.com

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.